Compare CareRx Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 200 Million (Small Cap)
7.00
NA
0.00%
0.25
25.38%
1.81
Revenue and Profits:
Net Sales:
94 Million
(Quarterly Results - Mar 2026)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.4%
0%
-14.4%
6 Months
-15.53%
0%
-15.53%
1 Year
8.45%
0%
8.45%
2 Years
42.67%
0%
42.67%
3 Years
41.41%
0%
41.41%
4 Years
-20.74%
0%
-20.74%
5 Years
-46.05%
0%
-46.05%
CareRx Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.23%
EBIT Growth (5y)
69.67%
EBIT to Interest (avg)
0.46
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
2.61
Tax Ratio
0.86%
Dividend Payout Ratio
9.60%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
4.21%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
1.81
EV to EBIT
17.85
EV to EBITDA
7.37
EV to Capital Employed
1.65
EV to Sales
0.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.24%
ROE (Latest)
25.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Dec 2016
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
93.90
96.10
-2.29%
Operating Profit (PBDIT) excl Other Income
8.00
7.50
6.67%
Interest
1.50
1.60
-6.25%
Exceptional Items
-0.20
-0.20
Consolidate Net Profit
1.20
23.80
-94.96%
Operating Profit Margin (Excl OI)
36.60%
31.20%
0.54%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -2.29% vs 3.11% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -94.96% vs 1,486.67% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
370.20
366.70
0.95%
Operating Profit (PBDIT) excl Other Income
30.20
26.60
13.53%
Interest
6.80
9.20
-26.09%
Exceptional Items
-1.40
-2.10
33.33%
Consolidate Net Profit
26.10
-4.50
680.00%
Operating Profit Margin (Excl OI)
32.10%
20.30%
1.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.95% vs -1.08% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 680.00% vs 16.67% in Dec 2024
About CareRx Corp. 
CareRx Corp.
Pharmaceuticals & Biotechnology
CareRx Corporation (CareRx), formerly Centric Health Corporation, is a Canada-based provider of pharmacy services and solutions to home operators and residents. The Company offers a range of medication solutions. CareRx provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The Company serves long-term care, retirement and assisted living, and supportive housing and group homes. CareRx offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.
Company Coordinates 
Company Details
20 Eglinton Ave W , TORONTO ON : M4R 1K8
Registrar Details






